Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.24.1.1.u2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Research and development $ 748,339 $ 1,089,342 $ 3,081,231 $ 4,183,038
General and administrative 915,912 1,774,699 3,887,157 5,106,172
Total operating expenses 1,664,251 2,864,041 6,968,388 9,289,210
Loss from operations (1,664,251) (2,864,041) (6,968,388) (9,289,210)
Other (income) expenses:        
Interest expense 59,696 91,534
Interest income (68,084) (79,152) (198,804) (92,401)
Other (2,321) 13,082 (9,384) 39,949
Other income, net (10,709) (66,070) (116,654) (52,452)
Net loss $ (1,653,542) $ (2,797,971) $ (6,851,734) $ (9,236,758)
Weighted average common shares outstanding, basic 25,933,217 25,633,217 25,784,853 24,888,916
Weighted average common shares outstanding, diluted 25,933,217 25,633,217 25,784,853 24,888,916
Net loss per share, basic $ (0.06) $ (0.11) $ (0.27) $ (0.37)
Net loss per share, diluted $ (0.06) $ (0.11) $ (0.27) $ (0.37)